Limited Utility of Dipyridamole-Thallium for Predicting Adverse Cardiac Events After Vascular Surgery

Abstract

The objective of this retrospective study was to determine the value of dipyridamolethallium (PTHAL) and Eagle criteria (Q wave on ECG, ventricular ectopy, diabetes, congestive heart failure, age >70, angina) in predicting cardiac events after vascular surgery at a Veteran Affairs hospital. The main outcome measures were adverse cardiac events. Of 211 vascular procedures, 148 were performed without, and 63 performed with, preoperative PTHAL. Thirty-six patients had redistribution on PTHAL, but only two underwent preoperative coronary revascularization. There were 10 cardiac events (4.8%), five in each group (p=NS). Cardiac events were increased with?one Eagle criteria (6.7% vs 0% with no Eagle, p=0.04), but not with PTHAL redistribution. Conclusions: Prior to elective vascular surgery: (1) PTHAL redistribution did not predict cardiac events. (2) Cardiac morbidity was increased with >one Eagle criteria. (3) Cardiac testing is not indicated in patients without Eagle criteria.

Get full access to this article

View all access options for this article.

References

1. Eagle KA , Coley CM , Newell JB , et al: Combining clinical and thallium data optimizes preoperative assessment of cardiac risk before major vascular surgery. Ann Intern Med 110:859-866, 1989.

2. Mangano DT , London MJ , Tubau JF , et al: Dipyridamole thallium-201 scintigraphy as a preoperative screening test: A reexamination of its predictive potential. Circulation 84:493-502, 1991.

3. Stratmann HG , Younis LT , Wittry MD , et al: Dipyridamole technetium-99m sestamibi myocardial tomography in patients evaluated for elective vascular surgery: Prognostic value for perioperative and late cardiac events. Am Heart J 131:923-929, 1995.

4. de Virgilio CM , Pak S , Arnell T , et al: Cardiac assessment prior to vascular surgery: Is dipyridamole-sestamibi necessary? Ann Vasc Surg 10:325-329, 1996.

5. Mangano DT , Goldman L : Preoperative assessment of patients with known or suspected coronary disease. N Engl J Med 333:1750-1756, 1995.

6. Boucher CA , Brewster DC , Darling RC , et al: Determination of cardiac risk by dipyridamole-thallium imaging before peripheral vascular surgery. N Engl J Med 312:389-394, 1985.

7. Bry JDL , Belkin M , O'Donnell TF , et al: An assessment of the positive predictive value and cost-effectiveness of dipyridamole myocardial scintigraphy in patients undergoing vascular surgery. J Vasc Surg 19:112-124, 1994.